n'-methyl-2-pyridone-5-carboxamide has been researched along with Chronic Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodeau, S; Boullier, A; Jonet, A; Kamel, S; Lemaire-Hurtel, AS; Lenglet, A; Liabeuf, S; Louvet, L; Mary, A; Massy, ZA; Sonnet, P | 1 |
| Itoh, H; Kanda, T; Notoya, M; Ono, T; Takahashi, R; Wakino, S; Yamada, K; Yoshimura, N; Yukioka, H | 1 |
1 review(s) available for n'-methyl-2-pyridone-5-carboxamide and Chronic Kidney Diseases
| Article | Year |
|---|---|
N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.
Topics: Animals; Humans; Niacinamide; Renal Insufficiency, Chronic; Toxins, Biological; Uremia | 2016 |
1 other study(ies) available for n'-methyl-2-pyridone-5-carboxamide and Chronic Kidney Diseases
| Article | Year |
|---|---|
N-methyl-2-pyridone-5-carboxamide (N-Me-2PY) has potent anti-fibrotic and anti-inflammatory activity in a fibrotic kidney model: is it an old uremic toxin?
Topics: Animals; Anti-Inflammatory Agents; Fibrosis; Interleukin-6; Kidney; Mice; NAD; Proto-Oncogene Proteins c-akt; Renal Insufficiency, Chronic; Uremic Toxins; Ureteral Obstruction | 2023 |